CGON vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CGON

39.3
AI Score
VS
SYRE Wins

SYRE

40.6
AI Score

Investment Advisor Scores

CGON

39score
Recommendation
SELL

SYRE

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CGON SYRE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 1982.7% 0.0% CGON
Earnings Growth 0.0% -99.7% CGON
Tradestie Score 39.3/100 40.6/100 SYRE
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD SYRE

Relative Price Performance (Last 90 Days)

CGON 1M: +12.2% · 3M: +23.6% SYRE 1M: +6.5% · 3M: +43.3%

Current Technical Phase

CGON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.3% over 20 days), RSI 61

RSI (14): 60.9 · Price: $79.81

SYRE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.1% over 20 days), RSI 58

RSI (14): 57.7 · Price: $106.49

Fundamentals Snapshot

Metric CGON SYRE
Market Cap
Forward P/E -26.4 -31.6
Trailing P/E
Revenue (TTM)
Revenue Growth 19.8% 0.0%
Gross Margin -25.9%
Operating Margin -74.7% 0.0%
EPS -2.58 -1.92
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.